DiaMedica Therapeutics Reports Full-Year 2025 Financial Results

What Happened
DiaMedica Therapeutics Inc. announced its consolidated financial results for the year ended December 31, 2025. The company released the results via a press release dated March 30, 2026, and filed a Current Report on Form 8‑K (filed March 31, 2026) to furnish that press release with the SEC.

Key Details

• The announcement covers consolidated financial results for the fiscal year ended December 31, 2025.
• The press release dated March 30, 2026 is attached to the Form 8‑K as Exhibit 99.1 and is incorporated by reference.
• The Form 8‑K (filed March 31, 2026) also includes the cover page in Inline XBRL as Exhibit 104.
• The 8‑K was filed under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits).

Why It Matters
This filing notifies investors that DiaMedica has publicly reported its full-year 2025 financial results; those results may contain important information on revenue, earnings, cash position and business trends. Retail investors should read the attached press release (Exhibit 99.1) and other SEC filings for the detailed financial figures and management commentary before making investment decisions.